One Biosciences ("One Biosciences" or the "Company"), a precision oncology techbio company pioneering clinical grade single-cell tumor transcriptomic profiling, today announced a €15 million Series A ...

One Biosciences has secured €15 million in Series A financing to expand its AI-powered single-cell transcriptomic platform, ...

Landmark preclinical data validate Renovaro's platform representing a step forward in the fight against pancreatic and solid tumors LOS ANGELES, CALIFORNIA / ACCESS Newswire / July 17, 2025 / Renovaro ...

Cogent Biosciences, Inc. (NASDAQ:COGT) is one of the 10 Best Small-Cap Stocks to Buy According to Billionaires. On July 7, ...

"Synthetic biology tools like optogenetics allow us to precisely tune complex cellular processes, something traditional drug screening cannot do," said Maxwell Wilson, Ph.D., Co-Founder and Chief ...

Aptose Biosciences Inc. ("Aptose" or the "Company") (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company developing a tuspetinib ...

A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, ...

Del-zota is designed for patients with mutations amenable to exon 44 skipping, which is just 7% of the overall DMD patient ...

Precision Reloading is excited to announce an important update to its range of outdoor products. Responding to the needs of ...

At last count, the stock was trading 5.21 per cent higher at Rs 478.90. Despite the day's gains, the stock remains down 19 per cent on a year-to-date (YTD) basis.

Fintel reports that on July 15, 2025, Piper Sandler initiated coverage of Precision Drilling (NYSE:PDS) with a Overweight ...